However, the regulation of ANT2 acetylation by PAK6 is independent of glutamine (Figure 4), which suggests that a high expression of PAK6 can maintain the protein stability and acetylation of ANT2 in the absence of glutamine, providing conditions for the survival of prostate cancer with the lack of glutamine. The gene discussed is PAK6; the disease is prostate carcinoma.